InvestorsHub Logo
Followers 4
Posts 86
Boards Moderated 0
Alias Born 05/12/2009

Re: None

Wednesday, 06/07/2017 4:03:10 PM

Wednesday, June 07, 2017 4:03:10 PM

Post# of 3987
This part of the
Press release is confusing me, is this a good thing? Can anybody put this in layman's terms? thanks


In addition to the ppFEV1 measurements taken during the study, an additional ppFEV1 measurement was taken two weeks after patients stopped treatment with alidornase alfa. For this measurement point, a mean decrease in ppFEV1 of -2.7 points was observed from the last alidornase alfa inhalation, while patients taken off Pulmozyme® at the beginning of the trial for two weeks experienced a mean decrease in ppFEV1 of only 0.06 points for the same off treatment duration.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PLX News